IOVANCE BIOTHERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2017-11-02: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement, effective August 14, 2017, between Timothy E. Morris and Registrant.*+.
- 2017-09-15: Form 8-K; Exhibit 10.1; Description Consulting Agreement, dated September 14, 2017, between Iovance Biotherapeutics, Inc. and Iain Dukes, D. Phil..
- 2017-08-03: Form 10-Q; Exhibit 10.1; Description Strategic Alliance Agreement, between Lion Biotechnologies, Inc. and The University of Texas M. D. Anderson Cancer Center, effective April 17, 2017.
- 2017-05-01: Form 8-K; Exhibit 10.1; Description Sublease Agreement, entered into as of April 28, 2017, between Lion Biotechnologies, Inc. and Teradata US, Inc..
| Filed | Form | Exhibit | Description |
|---|
| 2017-11-02 | 10-Q | 10.1 | Executive Employment Agreement, effective August 14, 2017, between Timothy E. Morris and Registrant.*+ |
|---|
| 2017-09-15 | 8-K | 10.1 | Consulting Agreement, dated September 14, 2017, between Iovance Biotherapeutics, Inc. and Iain Dukes, D. Phil. |
|---|
| 2017-08-03 | 10-Q | 10.1 | Strategic Alliance Agreement, between Lion Biotechnologies, Inc. and The University of Texas M. D. Anderson Cancer Center, effective April 17, 2017 |
|---|
| 2017-05-01 | 8-K | 10.1 | Sublease Agreement, entered into as of April 28, 2017, between Lion Biotechnologies, Inc. and Teradata US, Inc. |
|---|
| 2017-03-09 | 10-K | 10.37 | 2017 Corporate Goals-Cash Bonus Plan |
|---|
| 2017-03-09 | 10-K | 10.36 | Manufacturing Services Agreement, dated November 23, 2015, between WuXi AppTec, Inc. and Lion Biotechnologies, Inc. |
|---|
| 2017-03-09 | 10-K | 10.33 | Amended and Restated Executive Employment Agreement, dated January 27, 2017, by and among Lion Biotechnologies, Inc. and Michael T. Lotze.# |
|---|